3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
7
Wilms Tumor
6
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Multiple Myeloma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Myelodysplastic Syndromes
4
Lymphoma
4
Lung Neoplasms
4
Central Nervous System Neoplasms
4
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Mycosis Fungoides
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
Whole-Body Irradiation
5
Cyclophosphamide
5
fludarabine phosphate
4
Busulfan
4
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclosporine
3
fludarabine
2
Tacrolimus
2
Methotrexate
2
Etoposide
2
Azacitidine
2
Antilymphocyte Serum
2
venetoclax
1
merphos
1
ivosidenib
1
Vorinostat
1
Thiotepa
1
TAK-243
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Lenalidomide
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Biopsy
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
X-Rays
×
30 days
×
Clear all
No trials found.